What's breaking now, across thousands of outlets.
Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.
We haven't written up this one. NPR Health has the full story — the link below goes straight to it.
Medicare open enrollment runs through December 7, and these common errors can cost seniors money and access to care
Shortly after winning a clearance in the skin disease dermatomyositis, brepocitinib posted results suggesting it might also be a “best-in-disease” medicine for an inflammatory eye condition, one…
The Trump administration is withholding additional funds from California as part of its war with certain states over Medicaid fraud.
The Senate, on Wednesday, moved to prevent a full-blown Ebola crisis in Nigeria, adopting sweeping resolutions for compulsory health screening of all international travelers, immediate emergency…
SASKATOON, Saskatchewan, Oct. 21, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX), a Canadian pharmacy acquisition and ownership platform, announced today…
